Pelthos Therapeutics (PTHS) Shares Outstanding (Diluted) (2023 - 2026)
Pelthos Therapeutics' Shares Outstanding (Diluted) was 3.54 million in Q2 2026, up 452.6% from 640,518 a year earlier and up 6.9% from the prior quarter.
Powered by 
Analysis
Pelthos Therapeutics (PTHS) Shares Outstanding (Diluted) (2023 - 2026) Analysis & Trends
For FY2025, Shares Outstanding (Diluted) at Pelthos Therapeutics came in at 1.88 million, up 237.3% from FY2024.
- In earlier years, Shares Outstanding (Diluted) was 557,447 in FY2024 (+336.7%) and 127,654 in FY2023.
- The Q2 2026 figure marks the highest quarterly Shares Outstanding (Diluted) in data going back to Q4 2023.
- Compared with a year earlier, Shares Outstanding (Diluted) has increased for seven straight quarters, with growth averaging 276.7% over the last seven quarters.
- Per Business Quant data, PTHS's Shares Outstanding (Diluted) in the three quarters before Q2 2026 was 3.31 million (Q1 2026), 1.88 million (Q4 2025) and 3.06 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Pelthos Therapeutics | 79.95 Mn | -8.44 Mn | 11.99 Mn | 3.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.54 Mn |
| Mar 31, 2026 | 3.31 Mn |
| Dec 31, 2025 | 1.88 Mn |
| Sep 30, 2025 | 3.06 Mn |
| Jun 30, 2025 | 640,518.00 |
| Mar 31, 2025 | 612,792.00 |
| Dec 31, 2024 | 557,447.00 |
| Sep 30, 2024 | 579,229.00 |
| Jun 30, 2024 | 577,371.00 |
| Mar 31, 2024 | 469,099.00 |
| Dec 31, 2023 | 127,654.00 |
API Access
Pelthos Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=PTHS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "PTHS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=PTHS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();